Since the pandemic began in 2020, most of the discussions in the healthcare and pharma sectors have bordered on COVID-19, vaccines and the pandemic in general. And quite understandably, this is the most pressing health crisis facing the whole world.
However, according to Fastrading experts, there are other several issues that have been getting the attention of investors. For instance, the year-to-year healthcare venture fundraising rose up by 57% in 2020 which is about $17 billion. Therefore, regardless of the pandemic, some investment opportunities appeared to be opened in the healthcare sector.
The past 8 years have been very robust for the healthcare sector in terms of investment although 2020 came as a record-setting year. All the same, most of the records that were set in 2020 were apparently due to the pandemic and the trends are projected to continue in 2021.
Fastrading experts tried to bring everything to a proper perspective by highlighting the two main factors that contributed to the rise in the year-to-year venture fundraising in 2020. The highlighted factors include the influx of currency into the economy by different central banks of the world and the renewed attention placed on the importance of healthcare devices, therapeutics and diagnostics that are both related and non-related to COVID-19.
The two factors are just recent to be experienced. However, in the past 8 to 9 years, the healthcare sector had witnessed a high increase in constructive apparatus in-charge of drug approvals and regulations. More so, as innovation like this is further encouraged in 2021, there will be enough room for investment opportunities.
Also, if the accommodative monetary policies that have been witnessed in the healthcare sectors continue to thrive, Fastrading experts opined that many more research and innovative findings will grace the healthcare and pharma sectors in 2021 and more investment opportunities will open up to investors.